Understanding health students' knowledge of adverse drug reactions-Reference-Cited by-同舟云学术

Understanding health students' knowledge of adverse drug reactions

Published:2024-08-19 Issue:8 Volume:16 Page:e5202
ISSN:1989-4155
Container-title:Cuadernos de Educación y Desarrollo
language:
Short-container-title:Cuad. Ed. Desar.

Author:

Silva Sabrina Alexandre Ribeiro da,Barbosa Lívia Maria Sousa,Souza Guilherme Silva de,Diogo Renata Ferreira,Paiva Maykon Jhuly Martins de,Damasceno Iangla Araújo de Melo,Herrera Sávia Denise Silva Carlotto,Santos Taides Tavares dos

Abstract

This study investigated the knowledge of students from the Pharmacy, Nursing, Medicine, and Dentistry courses at UNITPAC regarding Adverse Drug Reactions (ADRs). A total of 111 students participated, with a percentage distribution per course of 34% in Pharmacy, 31% in Nursing, 20% in Medicine, and 15% in Dentistry. The results revealed that the majority of students acquired knowledge about pharmacovigilance and ADRs during their undergraduate studies, but there was variation among courses. Pharmacy had the highest knowledge index (71.1%) in pharmacovigilance, while Medicine had the greatest understanding of ADRs (72.7%). However, Nursing (26.5%) and Dentistry (17.6%) showed lower understanding of pharmacovigilance. Regarding knowledge about ADRs, Pharmacy (94.7%) and Medicine (72.7%) had the highest rates. In contrast, Nursing (73.5%) and Dentistry (41.2%) had lower comprehension. Polypharmacy was poorly understood, with 68.4% of Pharmacy students recognizing the term, compared to 17.6% of Dentistry students. The majority of students correctly defined ADRs, with Medicine (90.9%) and Pharmacy (89.5%) standing out. The research indicates the need for improvements in student education, especially in Nursing and Dentistry, to ensure a more comprehensive understanding and adequately prepare them to deal with ADRs in professional practice.

Publisher

South Florida Publishing LLC

Reference17 articles.

1. AGENCIA NACIONAL DE VIGILÂNCIA SANITÁRIA. Glossário da Resolução RDC nº 4, de 10 de fevereiro de 2009. 2009. Disponível em:< http://antigo.anvisa.gov.br/documents/33868/2894051/Gloss%C3%A1rio+da+R esolu%C3%A7%C3%A3o+RDC+n%C2%BA+4%2C+de+10+de+fevereiro+de+ 2009/61110af5-1749-47b4-9d81-ea5c6c1f322a>. Acessado em: 9 de janeiro de 2021.

2. ANVISA. AGENCIA NACIONAL DE VIGILÂNCIA SANITÁRIA. Resolução RDC 406/2020. 2020. Disponível em:< http://antigo.anvisa.gov.br/documents/10181/4858873/RDC_406_2020_.pdf/c62 cdded-e779-4021-858d-852edbd90178>. Acessado em 15 de outubro de 2020.

3. ALWHAIB, Monira; AL ALOOLA, Noha A. Healthcare students’ knowledge, attitude and perception of pharmacovigilance: A systematic review. PLoS One. 2020.

4. ARRAIS, Paulo Sérgio Dourado. Epidemiology of drug consumption and adverse events in the city of Fortaleza-CE. 2004. Disponível em:https://repositorio.ufba.br/ri/bitstream/ri/10905/1/22222222.pdf. Acessado em: 19 de outubro de 2020.

5. CARDOSO, Marco André; AMORIM, Márcia Aline Leal. Pharmacovigilance and its importance in monitoring adverse drug reactions. Revista Saúde e Desenvolvimento, v. 4, n. 2, p. 33-56, 2013.